Structure Therapeutics Investor Relations Material

Structure Therapeutics Inc., known by its Nasdaq ticker symbol GPCR, is a clinical-stage global biopharmaceutical company that focuses on designing innovative, orally available small molecule medicines. The company aims to transform the lives of patients worldwide by leveraging advanced computing and structure-based technologies. Its mission is to replace biologics and peptides with small-molecule drugs that offer life-changing solutions. The company is headquartered in San Francisco, California, and its shares are listed on the Nasdaq.